Literature DB >> 2649516

Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.

A J Naftilan1, R E Pratt, V J Dzau.   

Abstract

Recently, angiotensin II (Ang II) has been shown to cause hypertrophy of cultured quiescent rat aortic smooth muscle (RASM) cells. This observation along with the demonstration of angiotensinogen mRNA in the vessel wall has led us to postulate a role for vascular angiotensin in hypertensive blood vessel hypertrophy. To investigate further the possible molecular mechanisms, we examined the effect of Ang II on the expression of two genes known to be involved with cellular growth response. Near-confluent RASM cells were made quiescent by 48-h exposure to a defined serum-free medium. Ang II (10(-6) to 10(-11) M) resulted in an induction of the protooncogene c-myc mRNA within 30 min which persisted for 6 h. Interestingly, 6 h after the addition of Ang II, platelet-derived growth factor (PDGF) A-chain mRNA expression was elevated, peaked in 9 h, and persisted for 11 h. This was accompanied with a 15-20-fold increase in PDGF concentration in the culture medium. These effects were dose-dependent and were blocked by saralasin. Whereas the inhibition of protein synthesis by cycloheximide resulted in a stabilization of c-myc mRNA, cycloheximide abolished the elevation of the PDGF A-chain mRNA. Taken together, our data show that exposure of RASM cells to Ang II results in the sequential activation of c-myc and PDGF A-chain mRNA expressions. This sequential activation of protooncogene and growth factor gene may be an important mechanism in angiotensin-induced smooth muscle growth and hypertrophy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2649516      PMCID: PMC303838          DOI: 10.1172/JCI114032

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  34 in total

1.  Angiotensin II induces expression of the c-fos gene through protein kinase C activation and calcium ion mobilization in cultured vascular smooth muscle cells.

Authors:  Y Kawahara; M Sunako; T Tsuda; H Fukuzaki; Y Fukumoto; Y Takai
Journal:  Biochem Biophys Res Commun       Date:  1988-01-15       Impact factor: 3.575

2.  The fos gene as "master switch".

Authors:  J L Marx
Journal:  Science       Date:  1987-08-21       Impact factor: 47.728

3.  Antisense RNA of proto-oncogene c-fos blocks renewed growth of quiescent 3T3 cells.

Authors:  K Nishikura; J M Murray
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

4.  A common PDGF receptor is activated by homodimeric A and B forms of PDGF.

Authors:  J A Escobedo; S Navankasatussas; L S Cousens; S R Coughlin; G I Bell; L T Williams
Journal:  Science       Date:  1988-06-10       Impact factor: 47.728

Review 5.  Proto-oncogene fos: complex but versatile regulation.

Authors:  I M Verma; P Sassone-Corsi
Journal:  Cell       Date:  1987-11-20       Impact factor: 41.582

Review 6.  Importance of adaptive changes in vascular design for establishment of primary hypertension, studied in man and in spontaneously hypertensive rats.

Authors:  B Folkow; M Hallbäck; Y Lundgren; R Sivertsson; L Weiss
Journal:  Circ Res       Date:  1973-05-05       Impact factor: 17.367

7.  Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells.

Authors:  A A Geisterfer; M J Peach; G K Owens
Journal:  Circ Res       Date:  1988-04       Impact factor: 17.367

8.  Localization of angiotensinogen messenger RNA in rat aorta.

Authors:  L A Cassis; K R Lynch; M J Peach
Journal:  Circ Res       Date:  1988-06       Impact factor: 17.367

9.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

10.  Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types.

Authors:  C H Heldin; G Bäckström; A Ostman; A Hammacher; L Rönnstrand; K Rubin; M Nistér; B Westermark
Journal:  EMBO J       Date:  1988-05       Impact factor: 11.598

View more
  79 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 2.  Therapeutic effect on left ventricular hypertrophy by different antihypertensive drugs.

Authors:  W Motz; B E Strauer
Journal:  Clin Investig       Date:  1992

3.  Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal.

Authors:  J M Miano; R R Tota; N Vlasic; K J Danishefsky; M B Stemerman
Journal:  Am J Pathol       Date:  1990-10       Impact factor: 4.307

4.  Stimulation of endothelin mRNA and secretion in rat vascular smooth muscle cells: a novel autocrine function.

Authors:  A W Hahn; T J Resink; T Scott-Burden; J Powell; Y Dohi; F R Bühler
Journal:  Cell Regul       Date:  1990-08

5.  Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.

Authors:  G H Gibbons; R E Pratt; V J Dzau
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases.

Authors:  Jimmy Delaney; Roselynn Chiarello; David Villar; Umadevi Kandalam; Ana Maria Castejon; Michelle A Clark
Journal:  Neurochem Res       Date:  2007-09-01       Impact factor: 3.996

7.  Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin.

Authors:  D S Taylor; X Cheng; J E Pawlowski; A R Wallace; P Ferrer; C J Molloy
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

Review 8.  [The renin-angiotensin system in cardiovascular diseases].

Authors:  C Unterberg; H Kreuzer; A B Buchwald
Journal:  Med Klin (Munich)       Date:  1998-07-15

9.  Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.

Authors:  S Mäkimattila; P Summanen; I Matinlauri; M Mäntysaari; A Schlenzka; M Aalto; K Irjala; H Yki-Järvinen
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

10.  Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.

Authors:  H Itoh; M Mukoyama; R E Pratt; G H Gibbons; V J Dzau
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.